Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_assertion type Assertion NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_head.
- NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_assertion description "[Cross-talk between AKT and estrogen receptor beta-mediated transcription pathways may represent an important aspect that may influence breast cancer response to endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_provenance.
- NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_assertion evidence source_evidence_literature NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_provenance.
- NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_assertion SIO_000772 16951146 NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_provenance.
- NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_assertion wasDerivedFrom lhgdn-20090331 NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_provenance.
- NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_assertion wasGeneratedBy ECO_0000203 NP107616.RAZ0EwVa4PkqJRweMuxwXVU36bijAm4L6oO-iLjziycg8130_provenance.